Aero-OM, dimethicone

Land: Malta

Språk: engelsk

Kilde: Medicines Authority

Kjøp det nå

Preparatomtale Preparatomtale (SPC)
12-05-2024

Aktiv ingrediens:

DIMETICONE

Tilgjengelig fra:

OM PHARMA S.A. R. da Industria, 2, 2610-088 Amadora, Lisboa, Portugal

ATC-kode:

A02AF02

INN (International Name):

DIMETICONE 100 mg/ml

Legemiddelform:

ORAL DROPS, SOLUTION

Sammensetning:

DIMETICONE 100 mg/ml

Resept typen:

OTC

Terapeutisk område:

DRUGS FOR ACID RELATED DISORDERS

Autorisasjon status:

Withdrawn

Autorisasjon dato:

2006-11-21

Informasjon til brukeren

                                PROVA Nº 2
ORDEM DE FABRICO:
05-112597
ESPECIFICAÇÃO N.º:
1244L-3
FIBRA:
148
OPERADOR:
RM
DATA: 12/05/10
DIMENSÕES:
105 X 148
GRAMAGEM:
60G/M
2
CLIENTE:   OM PHARMA S.A.
CÓD.  2055405056
DESIGNAÇÃO:  
LIT  AERO OM INGLÊS
CÓD. LECTUS  319
CORES:
PRETO
Dimeticone
Tablets / oral drops (emulsion)
COMPOSITION:
Tablets:
Each tablet contains 40 mg of activated dimethylpolysiloxane.
Oral Drops (emulsion):
100 ml drops contains 10 g of activated dimethylpolysiloxane.
PRESENTATION:
Tablets: Packs of 20, 60 and 100 units.
Oral drops (emulsion): Bottle of 25 ml.
PHARMACOTHERAPEUTIC CATEGORY:
Group VII - 6 - d, antiflatulent.
MARKETING AUTHORIZATION HOLDER/MANUFACTURER:
OM PHARMA, S.A.
R. da Indústria, 2 – Quinta Grande
2610-088 – Amadora – Lisboa – Portugal
INDICATIONS:
Aerophagy and meteorism with ali their manifestations: abdominal
distension,
subcostal, epigastric and hypochondriac pain. Dyspnea an palpitation
(espe-
cially in cardiac and asthmatic patients) due to the raising of the
diaphragm. In
abdominal kidney and bone radiology.
In paediatrics: difficulty in burping and food regurgitation when
burping, in
infants, abdominal distension in children, flatulent colic.
CONTRA-INDICATIONS AND ADVERSE EFFECTS:
No known contra-indications or adverse effects.
INTERACTIONS:
No known interactions.
SPECIAL PRECAUTIONS:
Tablets should be chewed and not swailowed whole.
Diabetic patients or patients with low sugar diet have to be informed
that AERO-OM
contains saccharose (435 mg per tablet or 18 mg per drop).
EFFECTS ON PREGNANT WOMEN, INFANTS, CHILDREN, OLDER PEOPLE AND
PATIENTS
WITH SPECIAL ILLNESS:
No known contra-indications.
EFFECTS ON DRIVING ABILITY AND MACHINE OPERATIONS:
Non existent.
EXCIPIENTS:
Tablets: saccharose, povidone, colloidal anhydrous silica, magnesium
stearate, vanillin.
Oral drops (emulsion): saccharose, amaranth (E123), strawberry oil,
potassium
sorbate, purified water.
POSOLOGY:
a) Tablets:
Adult: two tablets or more after each meal.
b) Drops:
Infants: 10 drops, 3 or 4 times a 
                                
                                Les hele dokumentet
                                
                            

Preparatomtale

                                Page 1 of 3 
SUMMARY OF PRODUCT CHARACTERISTICS 
 
 
1.
 
NAME OF THE MEDICINAL PRODUCT 
Aero-OM

, dimethicone 
 
 
2.
 
QUALITATIVE AND QUANTITATIVE COMPOSITION 
Aero-OM - tablets : each tablet contains 40 mg of dimeticone 
Aero-OM - Oral emulsion : each millilitre contains 100 mg of dimeticone 
 
 
3.
 
PHARMACEUTICAL FORM 
Tablet and Oral emulsion 
 
 
4.
 
CLINICAL PARTICULARS 
 
4.1
 
THERAPEUTIC INDICATIONS 
Aerophagia and meteorism with all manifestations forms, namely distension and 
abdominal pain. Preparation for abdominal, renal and bone radiology. 
In  pediatrics :  Symptoms  cause  by  the  swallowing  of  gas  and  Adjuvant  in  the 
management of recurrent abdominal pain or infant colic. 
 
4.2.
 
POSOLOGY AND METHOD OF ADMINISTRATION 
ADULTS : 2 tablets 4 times daily after meals_ _
CHILDREN UNDER 12 MONTHS : 5 to 10 drops 3 or 4 daily 
CHILDREN WITH 12 MONTHS AND OLDER : 10 drops or one tablet 3 or 4 times daily 
The tablets must be chewed and not swallowed entire. 
 
4.3.
 
CONTRAINDICATIONS 
Contra-indications are unknown for dimethicone. 
 
4.4.
 
SPECIAL WARNINGS AND SPECIAL PRECAUTIONS FOR USE 
The tablets have to be chewed and not swallowed entire. 
 
4.5.
 
INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF INTERACTION 
Unknown. 
 
4.6
 
PREGNANCY AND LACTATION 
Contra-indications  are  unknown  in  Aero-OM  administration  during  pregnancy 
and lactation. 
 
4.7.
 
EFFECTS ON ABILITY TO DRIVE  AND USE MACHINES 
Unknown. 
 
4.8.
 
UNDESIREABLE EFFECTS 
Unkown. 
 
 
Page 2 of 3 
4.9.
 
OVERDOSE 
Cases of overdose are unknown. 
 
5.
 
PHARMACOLOGICAL PROPERTIES 
 
5.1.
 
PHARMACODYNAMIC PROPERTIES 
Aero-OM belongs to pharmacotherapeutic group VII-6.d : antiflatulents. 
Whatever  their  origin,  
                                
                                Les hele dokumentet
                                
                            

Søk varsler relatert til dette produktet